XPS™ with Steen Solution™ Perfusate

Normothermic Preservation System For Transplantation Of Initially Unacceptable Donor Lungs

FDA Premarket Approval P180014

Pre-market Approval Supplement Details

This device is indicated for use in flushing and temporary continuous normothermic machine perfusion of initially unacceptable excised donor lungs during which time the ex vivo function of the lungs can be reassessed for transplantation.

DeviceXPS™ with Steen Solution™ Perfusate
Classification NameNormothermic Preservation System For Transplantation Of Initially Unacceptable Donor Lungs
Generic NameNormothermic Preservation System For Transplantation Of Initially Unacceptable Donor Lungs
ApplicantXVIVO Perfusion, Inc.
Date Received2018-05-10
Decision Date2019-04-26
PMAP180014
SupplementS
Product CodePHO
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product Yes
Applicant Address XVIVO Perfusion, Inc. 3666 S. Inca Street englewood, CO 80110

Supplemental Filings

Supplement NumberDateSupplement Type
P180014Original Filing
S009 2022-02-08 Real-time Process
S008 2022-02-08 Real-time Process
S007
S006 2021-10-04 Normal 180 Day Track No User Fee
S005 2020-09-23 Normal 180 Day Track No User Fee
S004 2020-01-27 Real-time Process
S003 2020-01-27 Real-time Process
S002
S001 2019-05-28 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
07350069520500 P180014 000
07350069520401 P180014 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.